Cardio Diagnostics Holdings (NASDAQ: CDIO) is advancing artificial intelligence solutions for cardiovascular disease detection and management, focusing on developing blood tests that combine AI with multi-omic biomarkers to provide actionable insights for clinicians. The company aims to lower barriers to advanced cardiovascular testing by utilizing a simple blood sample, enabling more informed and timely care decisions.
Cardiovascular disease remains one of the most serious and costly health challenges worldwide, driving an urgent need for earlier detection and more precise, personalized treatment strategies. According to the Centers for Disease Control and Prevention, heart disease remains the leading cause of death in the United States, responsible for approximately one in every three deaths. The scale and impact of cardiovascular disease underscore why innovation in this area is so critical.
Advances in genomics and epigenetics are making it possible to better understand how genetic predisposition and environmental influences interact to drive disease progression. By utilizing a simple blood test, Cardio Diagnostics is lowering barriers to advanced cardiovascular testing. The company's approach leverages artificial intelligence and multi-omic biomarkers to deliver actionable insights from a simple blood sample, enabling more informed and timely cardiac care decisions.
The latest news and updates relating to CDIO are available in the company’s newsroom at https://ibn.fm/CDIO. For full terms of use and disclaimers, please see the InvestorBrandNetwork website at http://IBN.fm/Disclaimer.
Forward-looking statements in this article involve risks and uncertainties that may cause actual results to differ materially. These include factors set forth under "Risk Factors" in the Company's most recent Annual Report on Form 10-K or any updates in subsequent filings with the SEC. Undue reliance should not be placed on forward-looking statements, which are based on information available as of the date hereof. The Company undertakes no duty to update this information unless required by law.
